Landiolol
Records for this ingredient, by country (identity only).
ATC C07AB14 · 7 markets · 13 records
JP 5 records · 3 shown of 3
- 150 mg per mL / per unit basis not statedinjectionオノアクト点滴静注用150mgランジオロール塩酸塩点滴静注用150mg「F」
- 50 mg per mL / per unit basis not statedinjectionオノアクト点滴静注用150mgランジオロール塩酸塩点滴静注用150mg「F」
- 12.5 mg per mL / per unit basis not statedinjectionコアベータ静注用12.5mg
AU 2 records · 1 shown of 1
- 300 mg per mL / per unit basis not statedinjectionRAPIBLYK landiolol hydrochloride 300 mg powder for injection vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名RAPIBLYK ×1
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 2 records · 2 shown of 2
- 300 mg per mL / per unit basis not statedinjectionRAPIBLOC 300 mg, poudre pour solution pour perfusion
- 20 mg/2 mLinjectionRAPIBLOC 20 mg/2 ml, solution à diluer injectable
US 1 records · 1 shown of 1
- 280 mg per mL / per unit basis not statedinjectionRAPIBLYK
GB 1 records · 1 shown of 1
- 300 mg per mL / per unit basis not statedinjectionRapibloc 300mg powder for solution for infusion vials
ES 1 records · 1 shown of 1
- 300 mg per mL / per unit basis not statedinjectionRAPIBLOC
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.